Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
04/05/2022
22/04/2022
14/04/2022
18/03/2022
15/03/2022
02/03/2022
24/02/2022
22/02/2022
21/02/2022
10/12/2020
15/02/2022
11/02/2022
08/02/2022
28/01/2022
25/01/2022
19/01/2022
14/01/2022
11/01/2022
07/01/2022
05/01/2022
04/01/2022
15/12/2021